Already a DIA Member? Sign in. Not a member? Join.

Iniciar sesión

¿Ha olvidado su ID de usuario? or ¿Ha olvidado su contraseña?

Not a Member?

Create Account and Join

Virtual

09 nov 2020 10:00 a.m. - 10 nov 2020 3:45 p.m.

(US Eastern Standard Time)

Real World Evidence Conference

Session 6: COVID-19 Hot Topics: Rapid Responses of the RWE Community

Session Chair(s)

Marni  Hall, PhD, MPH

Marni Hall, PhD, MPH

Vice President and General Manager, Global Regulatory Science and Strategy

IQVIA, United States

Richard  Forshee, PhD

Richard Forshee, PhD

Deputy Director, OBPV CBER

FDA, United States

This session provides examples of the role RWE plays to inform the pandemic response. Specific use cases including evaluation of the natural history of the disease, comparative studies of therapeutics, and establishment of a near real-time community reporting system. An emphasis will be placed on lessons learned from the need for rapid collaboration and adaptation.

Learning Objective : At the conclusion of this session, participants should be able to:
  • List key uses for RWE in the COVID-19 pandemic
  • Discuss representative COVID-19 pandemic RWD sources and their strengths and limitations
  • Apply lessons learned from collaborative COVID-19 pandemic RWE partnerships to future activities

Speaker(s)

Robert  Ball, MD, MPH, MSc

Speaker

Robert Ball, MD, MPH, MSc

FDA, United States

Deputy Director, Office of Surveillance and Epidemiology, CDER

Patrick  Ryan

Speaker

Patrick Ryan

Janssen Pharmaceuticals, Inc., United States

Head, Epidemiology Analytics

Jeff  Allen, PhD

Speaker

Jeff Allen, PhD

Friends of Cancer Research, United States

President and Chief Executive Officer

Nancy A Dreyer, PhD, MPH, FISPE

Speaker

Nancy A Dreyer, PhD, MPH, FISPE

Dreyer Strategies LLC, United States

Founder

¿Tiene una cuenta?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.